Bionova Capital

investment firm

About

Bionova Capital is a healthcare-focused venture capital firm, investing in early-stage startups across Europe.

Details

Industries
Biotechnology,Life Science,Venture Capital
Founded date
May 13, 2015
Operating Status
Active
Legal Name
Bionova Capital, Sociedade de Capital de Risco, S.A.
Investor Type
Venture Capital

Bionova Capital, previously known as Hovione Capital, is a healthcare-focused venture capital firm, investing in early-stage life science companies. It was founded in 2015 by the shareholders of Hovione, one of the largest pharmaceutical companies in Portugal, with manufacturing and research operations in USA, Ireland, China and Portugal. Bionova Capital invests in groundbreaking therapeutics, medtech and digital health startups across Europe.

Investments

Number of Investments
Number of Lead Investments
7
1
Bionova Capital has made 7 investments. Their most recent investment was on May 18, 2022, when Delox raised €750K.
Date Company Name
Round Money Raised Industry Lead Investor
May 18, 2022 Delox
Seed €750K Biotechnology
Aug 9, 2021 SolasCure
Series A £15M Biopharma
Mar 23, 2021 Adapttech
Series Unknown £2M Biotechnology Yes
Nov 13, 2019 CellmAbs
Seed $1.60M Biotechnology
Jul 1, 2018 Delox
Seed €300K Biotechnology

Employee Profiles

Number of Employee Profiles
5
Bionova Capital has 5 current employee profiles, including Executive Peter Villax